Heike E. Daldrup‐Link

A phase I study of zoledronic acid and low‐dose cyclophosphamide in recurrent/refractory neuroblastoma: A new approaches to neuroblastoma therapy (NANT) study

S. Groshen, H. Daldrup-Link, K. Matthay, 2011, Pediatric blood & cancer.